BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1823843)

  • 1. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
    Hoefnagel CA; Schornagel J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
    Colombo L; Lomuscio G; Vignati A; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
    Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
    J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
    Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
    J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
    Fischer M
    J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Nucl Biol Med (1991); 1991; 35(4):284-7. PubMed ID: 1823837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
    Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
    J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
    Hoefnagel CA; Taal BG; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.
    Ackery DM; Troncone L
    J Nucl Biol Med (1991); 1991; 35(4):318-20. PubMed ID: 1823846
    [No Abstract]   [Full Text] [Related]  

  • 16. 131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.
    Sakahara H; Endo K; Saga T; Hosono M; Kobayashi H; Konishi J
    Ann Nucl Med; 1994 May; 8(2):133-7. PubMed ID: 7521194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic possibilities in metastatic pheochromocytoma].
    Vierhapper H; Raber W
    Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
    Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
    Khafagi FA; Shapiro B; Fig LM; Mallette S; Sisson JC
    J Nucl Med; 1989 Apr; 30(4):481-9. PubMed ID: 2738677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.